Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1995 Jun;32(6):411–414. doi: 10.1136/jmg.32.6.411

Nuclear and mitochondrial genetics in Parkinson's disease.

A H Schapira 1
PMCID: PMC1050479  PMID: 7666391

Full text

PDF
411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Muramatsu T., Higuchi S., Sasaki H., Trojanowski J. Q. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet. 1994 Sep 24;344(8926):889–889. doi: 10.1016/s0140-6736(94)92862-2. [DOI] [PubMed] [Google Scholar]
  2. Armstrong M., Daly A. K., Cholerton S., Bateman D. N., Idle J. R. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet. 1992 Apr 25;339(8800):1017–1018. doi: 10.1016/0140-6736(92)90537-d. [DOI] [PubMed] [Google Scholar]
  3. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415–455. doi: 10.1016/0022-510x(73)90175-5. [DOI] [PubMed] [Google Scholar]
  4. Brooks D. J., Ibanez V., Sawle G. V., Quinn N., Lees A. J., Mathias C. J., Bannister R., Marsden C. D., Frackowiak R. S. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol. 1990 Oct;28(4):547–555. doi: 10.1002/ana.410280412. [DOI] [PubMed] [Google Scholar]
  5. Burn D. J., Mark M. H., Playford E. D., Maraganore D. M., Zimmerman T. R., Jr, Duvoisin R. C., Harding A. E., Marsden C. D., Brooks D. J. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 1992 Oct;42(10):1894–1900. doi: 10.1212/wnl.42.10.1894. [DOI] [PubMed] [Google Scholar]
  6. Calne D. B., Langston J. W., Martin W. R., Stoessl A. J., Ruth T. J., Adam M. J., Pate B. D., Schulzer M. Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease. Nature. 1985 Sep 19;317(6034):246–248. doi: 10.1038/317246a0. [DOI] [PubMed] [Google Scholar]
  7. Degl'Innocenti F., Maurello M. T., Marini P. A parkinsonian kindred. Ital J Neurol Sci. 1989 Jun;10(3):307–310. doi: 10.1007/BF02333776. [DOI] [PubMed] [Google Scholar]
  8. Duvoisin R. C., Eldridge R., Williams A., Nutt J., Calne D. Twin study of Parkinson disease. Neurology. 1981 Jan;31(1):77–80. doi: 10.1212/wnl.31.1.77. [DOI] [PubMed] [Google Scholar]
  9. Gasser T., Wszolek Z. K., Trofatter J., Ozelius L., Uitti R. J., Lee C. S., Gusella J., Pfeiffer R. F., Calne D. B., Breakefield X. O. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol. 1994 Sep;36(3):387–396. doi: 10.1002/ana.410360310. [DOI] [PubMed] [Google Scholar]
  10. Golbe L. I., Di Iorio G., Bonavita V., Miller D. C., Duvoisin R. C. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol. 1990 Mar;27(3):276–282. doi: 10.1002/ana.410270309. [DOI] [PubMed] [Google Scholar]
  11. Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992 Jun;42(6):1142–1146. doi: 10.1212/wnl.42.6.1142. [DOI] [PubMed] [Google Scholar]
  12. Janetzky B., Hauck S., Youdim M. B., Riederer P., Jellinger K., Pantucek F., Zöchling R., Boissl K. W., Reichmann H. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett. 1994 Mar 14;169(1-2):126–128. doi: 10.1016/0304-3940(94)90372-7. [DOI] [PubMed] [Google Scholar]
  13. Jenner P., Dexter D. T., Sian J., Schapira A. H., Marsden C. D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol. 1992;32 (Suppl):S82–S87. doi: 10.1002/ana.410320714. [DOI] [PubMed] [Google Scholar]
  14. Johnson W. G., Hodge S. E., Duvoisin R. Twin studies and the genetics of Parkinson's disease--a reappraisal. Mov Disord. 1990;5(3):187–194. doi: 10.1002/mds.870050302. [DOI] [PubMed] [Google Scholar]
  15. Kurth J. H., Kurth M. C., Poduslo S. E., Schwankhaus J. D. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol. 1993 Apr;33(4):368–372. doi: 10.1002/ana.410330406. [DOI] [PubMed] [Google Scholar]
  16. Langston J. W., Forno L. S., Rebert C. S., Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 1984 Feb 6;292(2):390–394. doi: 10.1016/0006-8993(84)90777-7. [DOI] [PubMed] [Google Scholar]
  17. Lazzarini A. M., Myers R. H., Zimmerman T. R., Jr, Mark M. H., Golbe L. I., Sage J. I., Johnson W. G., Duvoisin R. C. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology. 1994 Mar;44(3 Pt 1):499–506. doi: 10.1212/wnl.44.3_part_1.499. [DOI] [PubMed] [Google Scholar]
  18. Lestienne P., Nelson I., Riederer P., Reichmann H., Jellinger K. Mitochondrial DNA in postmortem brain from patients with Parkinson's disease. J Neurochem. 1991 May;56(5):1819–1819. doi: 10.1111/j.1471-4159.1991.tb02087.x. [DOI] [PubMed] [Google Scholar]
  19. Mann V. M., Cooper J. M., Daniel S. E., Srai K., Jenner P., Marsden C. D., Schapira A. H. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol. 1994 Dec;36(6):876–881. doi: 10.1002/ana.410360612. [DOI] [PubMed] [Google Scholar]
  20. Mann V. M., Cooper J. M., Krige D., Daniel S. E., Schapira A. H., Marsden C. D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain. 1992 Apr;115(Pt 2):333–342. doi: 10.1093/brain/115.2.333. [DOI] [PubMed] [Google Scholar]
  21. Mann V. M., Cooper J. M., Schapira A. H. Quantitation of a mitochondrial DNA deletion in Parkinson's disease. FEBS Lett. 1992 Mar 16;299(3):218–222. doi: 10.1016/0014-5793(92)80118-z. [DOI] [PubMed] [Google Scholar]
  22. Marder K., Maestre G., Cote L., Mejia H., Alfaro B., Halim A., Tang M., Tycko B., Mayeux R. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology. 1994 Jul;44(7):1330–1331. doi: 10.1212/wnl.44.7.1330. [DOI] [PubMed] [Google Scholar]
  23. Marsden C. D. Parkinson's disease in twins. J Neurol Neurosurg Psychiatry. 1987 Jan;50(1):105–106. doi: 10.1136/jnnp.50.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Marttila R. J., Kaprio J., Koskenvuo M., Rinne U. K. Parkinson's disease in a nationwide twin cohort. Neurology. 1988 Aug;38(8):1217–1219. doi: 10.1212/wnl.38.8.1217. [DOI] [PubMed] [Google Scholar]
  25. Ozawa T., Tanaka M., Ikebe S., Ohno K., Kondo T., Mizuno Y. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem Biophys Res Commun. 1990 Oct 30;172(2):483–489. doi: 10.1016/0006-291x(90)90698-m. [DOI] [PubMed] [Google Scholar]
  26. Ozawa T., Tanaka M., Ino H., Ohno K., Sano T., Wada Y., Yoneda M., Tanno Y., Miyatake T., Tanaka T. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun. 1991 Apr 30;176(2):938–946. doi: 10.1016/s0006-291x(05)80276-1. [DOI] [PubMed] [Google Scholar]
  27. Prezant T. R., Agapian J. V., Bohlman M. C., Bu X., Oztas S., Qiu W. Q., Arnos K. S., Cortopassi G. A., Jaber L., Rotter J. I. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993 Jul;4(3):289–294. doi: 10.1038/ng0793-289. [DOI] [PubMed] [Google Scholar]
  28. Rempfer R., Crook R., Houlden H., Duff K., Hutton M., Roberts G. W., Raghavan R., Perry R., Hardy J. Parkinson's disease, but not Alzheimer's disease, Lewy body variant associated with mutant alleles at cytochrome P450 gene. Lancet. 1994 Sep 17;344(8925):815–815. doi: 10.1016/s0140-6736(94)92370-1. [DOI] [PubMed] [Google Scholar]
  29. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59–62. doi: 10.1038/362059a0. [DOI] [PubMed] [Google Scholar]
  30. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  31. Sawle G. V., Wroe S. J., Lees A. J., Brooks D. J., Frackowiak R. S. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred. Ann Neurol. 1992 Nov;32(5):609–617. doi: 10.1002/ana.410320503. [DOI] [PubMed] [Google Scholar]
  32. Schapira A. H., Cooper J. M., Dexter D., Clark J. B., Jenner P., Marsden C. D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem. 1990 Mar;54(3):823–827. doi: 10.1111/j.1471-4159.1990.tb02325.x. [DOI] [PubMed] [Google Scholar]
  33. Schapira A. H., Cooper J. M. Mitochondrial function in neurodegeneration and ageing. Mutat Res. 1992 Sep;275(3-6):133–143. doi: 10.1016/0921-8734(92)90018-k. [DOI] [PubMed] [Google Scholar]
  34. Schapira A. H. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal. Mov Disord. 1994 Mar;9(2):125–138. doi: 10.1002/mds.870090202. [DOI] [PubMed] [Google Scholar]
  35. Schapira A. H., Holt I. J., Sweeney M., Harding A. E., Jenner P., Marsden C. D. Mitochondrial DNA analysis in Parkinson's disease. Mov Disord. 1990;5(4):294–297. doi: 10.1002/mds.870050406. [DOI] [PubMed] [Google Scholar]
  36. Schapira A. H., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B., Marsden C. D. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem. 1990 Dec;55(6):2142–2145. doi: 10.1111/j.1471-4159.1990.tb05809.x. [DOI] [PubMed] [Google Scholar]
  37. Shoffner J. M., Brown M. D., Torroni A., Lott M. T., Cabell M. F., Mirra S. S., Beal M. F., Yang C. C., Gearing M., Salvo R. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics. 1993 Jul;17(1):171–184. doi: 10.1006/geno.1993.1299. [DOI] [PubMed] [Google Scholar]
  38. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  39. Steiger M. J., Lledo P., Quinn N. P., Marsden C. D., Turner P., Jenner P. G. Debrisoquine hydroxylation in Parkinson's disease. Acta Neurol Scand. 1992 Aug;86(2):159–164. doi: 10.1111/j.1600-0404.1992.tb05059.x. [DOI] [PubMed] [Google Scholar]
  40. Steventon G. B., Heafield M. T., Waring R. H., Williams A. C. Xenobiotic metabolism in Parkinson's disease. Neurology. 1989 Jul;39(7):883–887. doi: 10.1212/wnl.39.7.883. [DOI] [PubMed] [Google Scholar]
  41. Tipton K. F., Singer T. P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem. 1993 Oct;61(4):1191–1206. doi: 10.1111/j.1471-4159.1993.tb13610.x. [DOI] [PubMed] [Google Scholar]
  42. Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983 Jul;33(7):815–824. doi: 10.1212/wnl.33.7.815. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES